ID   UCR8
AC   CVCL_C9BV
SY   Union hospital Cervical cancer Radioresistant 8
DR   Wikidata; Q123033680
RX   PubMed=36867313;
CC   Population: Chinese.
CC   Doubling time: 1.567 days (PubMed=36867313).
CC   Transformant: NCBI_TaxID; 333760; Human papillomavirus type 16 (HPV16).
CC   Derived from site: In situ; Uterus, cervix; UBERON=UBERON_0000002.
ST   Source(s): PubMed=36867313
ST   Amelogenin: X
ST   CSF1PO: 11,12
ST   D12S391: 20
ST   D13S317: 11
ST   D16S539: 12
ST   D18S51: 13,18
ST   D19S433: 13
ST   D1S1656: 16,17
ST   D21S11: 31
ST   D2S1338: 19
ST   D3S1358: 15
ST   D5S818: 7,12
ST   D6S1043: 14
ST   D7S820: 8
ST   D8S1179: 10
ST   FGA: 24,26
ST   Penta D: 10,13
ST   Penta E: 15
ST   TH01: 9
ST   TPOX: 8
ST   vWA: 16
DI   NCIt; C27676; Human papillomavirus-related cervical squamous cell carcinoma
DI   ORDO; Orphanet_213767; Squamous cell carcinoma of the cervix uteri
OX   NCBI_TaxID=9606; ! Homo sapiens (Human)
SX   Female
AG   69Y
CA   Cancer cell line
DT   Created: 05-10-23; Last updated: 30-01-24; Version: 2
//
RX   PubMed=36867313; DOI=10.1007/s13577-023-00882-x; PMCID=PMC10110719;
RA   Xing B.-Y., Pu C.-L., Chen Y.-S., Sheng Y.-H., Zhang B.-F., Cui J.,
RA   Wu G., Zhao Y.-C.;
RT   "Insights into the characteristics of primary radioresistant cervical
RT   cancer using single-cell transcriptomics.";
RL   Hum. Cell 36:1135-1146(2023).
//